Autologous adipose tissue-derived mesenchymal progenitor cells (MPCs) therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous adipose tissue-derived mesenchymal progenitor cells (MPCs) therapy, covering 2017-11-17 to 2017-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis [Phase 2]